Published in Clin Microbiol Rev on April 01, 2000
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med (2003) 10.20
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A (2006) 4.54
A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol (2002) 3.20
CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A (2004) 3.01
Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol (2002) 1.78
Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. PLoS Pathog (2007) 1.56
Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol (2003) 1.50
The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol (2008) 1.49
Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol (2002) 1.46
Analysis of the 5' noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol (2006) 1.33
Hepatitis C virus NS3 ATPases/helicases from different genotypes exhibit variations in enzymatic properties. J Virol (2003) 1.31
Production of infectious hepatitis C virus of various genotypes in cell cultures. J Virol (2007) 1.27
In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A. Antimicrob Agents Chemother (2014) 1.23
The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells. Cell Host Microbe (2011) 1.22
In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450. Antimicrob Agents Chemother (2014) 1.20
Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a. Antimicrob Agents Chemother (2010) 1.17
Evidence of recombination in intrapatient populations of hepatitis C virus. PLoS One (2008) 1.16
Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol (2006) 1.16
Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III. J Virol (2011) 1.09
Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J (2011) 1.06
Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. Hepat Mon (2012) 1.05
Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors. Antimicrob Agents Chemother (2008) 1.05
In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitor. Antimicrob Agents Chemother (2014) 1.05
Recombination in hepatitis C virus. Viruses (2011) 1.05
Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4. J Clin Microbiol (2004) 1.04
Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients. Virol J (2010) 1.03
Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase. Antimicrob Agents Chemother (2009) 1.03
Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol (2005) 1.02
Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS One (2012) 1.01
Assessment of viral genotype impact to the cost-effectiveness and overall costs of care for PEG-interferon-2α + ribavirine treated chronic hepatitis C patients. Hepat Mon (2013) 1.00
Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. J Clin Microbiol (2007) 1.00
Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies. Hepatology (2013) 0.99
Rapid genotyping of hepatitis C virus by primer-specific extension analysis. J Clin Microbiol (2005) 0.98
Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection. Blood (2007) 0.98
Methamphetamine enhances Hepatitis C virus replication in human hepatocytes. J Viral Hepat (2008) 0.97
Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance. World J Gastroenterol (2007) 0.97
High prevalence of hepatitis C virus type 5 in central France evidenced by a prospective study from 1996 to 2002. J Clin Microbiol (2004) 0.96
Computer-aided identification of polymorphism sets diagnostic for groups of bacterial and viral genetic variants. BMC Bioinformatics (2007) 0.95
Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays. Asian J Transfus Sci (2014) 0.95
Matrix-assisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping. J Clin Microbiol (2005) 0.94
Prevalence of hepatitis C virus infections and distribution of hepatitis C virus genotypes among Korean blood donors. Ann Lab Med (2012) 0.94
Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection. Cell Mol Immunol (2014) 0.94
HCV genotyping using statistical classification approach. J Biomed Sci (2009) 0.92
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance. Viruses (2015) 0.92
The p7 protein of hepatitis C virus forms structurally plastic, minimalist ion channels. PLoS Comput Biol (2012) 0.90
Different HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, China. PLoS One (2012) 0.89
Diabetes and Hepatitis C: A Two-Way Association. Front Endocrinol (Lausanne) (2015) 0.89
Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C. Viruses (2010) 0.87
An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol (2013) 0.87
Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China. World J Gastroenterol (2008) 0.87
Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes. J Clin Microbiol (2001) 0.87
Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A. Antimicrob Agents Chemother (2013) 0.87
Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1-6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance. Viruses (2015) 0.86
Genetic history of hepatitis C virus in Venezuela: high diversity and long time of evolution of HCV genotype 2. PLoS One (2010) 0.86
Genotyping Pattern among Iranian HCV Positive Patients. Iran J Public Health (2010) 0.86
Evaluation of a new serotyping assay for detection of anti-hepatitis C virus type-specific antibodies in serum samples. J Clin Microbiol (2003) 0.85
Preclinical characterization of JTK-853, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase. Antimicrob Agents Chemother (2012) 0.84
Managing chronic hepatitis C in the difficult-to-treat patient. Liver Int (2007) 0.84
Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol (2016) 0.84
Genotyping hepatitis C virus by heteroduplex mobility analysis using temperature gradient capillary electrophoresis. J Clin Microbiol (2004) 0.84
Determination of hepatitis C genotypes and the viral titer distribution in children and adolescents with major thalassemia. Iran J Pediatr (2010) 0.83
Hepatitis C virus isolates from Argentina disclose a novel genotype 1-associated restriction pattern. J Clin Microbiol (2004) 0.83
In vitro detection of dissimilar amounts of hepatitis C virus (HCV) subtype-specific RNA genomes in mixes prepared from sera of persons infected with a single HCV genotype. J Clin Microbiol (2003) 0.83
Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review. Patient Prefer Adherence (2013) 0.83
Regulation of neuronal proapoptotic potassium currents by the hepatitis C virus nonstructural protein 5A. J Neurosci (2012) 0.82
Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiol Infect (2006) 0.82
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b. BMC Gastroenterol (2012) 0.82
Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan. Virol J (2011) 0.82
Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form. Int J Mol Sci (2016) 0.81
Heterogeneity and new epitopes of hepatitis C virus genotype 4. Hepat Mon (2013) 0.81
Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina. Bosn J Basic Med Sci (2009) 0.81
Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia. J Med Virol (2012) 0.80
Hepatitis C in hemodialysis patients. World J Hepatol (2015) 0.80
Distribution of Hepatitis C Virus Genotypes in Bahrain. Hepat Mon (2015) 0.80
Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil. BMC Infect Dis (2008) 0.80
Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission. BMC Res Notes (2015) 0.80
A reliable multiplex genotyping assay for HCV using a suspension bead array. Microb Biotechnol (2014) 0.80
Comprehensive Screening for Naturally Occurring Hepatitis C Virus Resistance to Direct-Acting Antivirals in the NS3, NS5A, and NS5B Genes in Worldwide Isolates of Viral Genotypes 1 to 6. Antimicrob Agents Chemother (2016) 0.80
Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America. World J Gastroenterol (2016) 0.80
Determining major genotypes of hepatitis C virus among transplant recipients by real-time polymerase chain reaction assay. Jundishapur J Microbiol (2015) 0.79
Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase. J Med Chem (2011) 0.79
Dilemma of HCV infection in renal transplant recipients. Int J Nephrol (2011) 0.79
Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice. Hepat Mon (2014) 0.79
Distribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalised in bydgoszcz. Hepat Mon (2014) 0.79
Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience. Clin Mol Hepatol (2012) 0.79
Distribution of Hepatitis C virus (HCV) genotypes in seropositive patients in the state of Alagoas, Brazil. Braz J Microbiol (2008) 0.79
Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional study. Virol J (2009) 0.78
Serological assay and genotyping of hepatitis C virus in infected patients in zanjan province. Hepat Mon (2014) 0.78
The "hidden" epidemic: a snapshot of Moroccan intravenous drug users. Virol J (2014) 0.78
Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir. Int J Organ Transplant Med (2015) 0.78
Prevalence of hepatitis C virus genotypes in district bannu, khyber pakhtunkhwa, pakistan. Hepat Res Treat (2014) 0.78
Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion. Exp Ther Med (2016) 0.77
The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon (2016) 0.77
Change in hepatitis C virus clades: a cross-sectional study of chronic HCV patients in Pakistan from 2000-2010. Eur J Clin Microbiol Infect Dis (2011) 0.77
Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China. PLoS One (2014) 0.76
Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt. Hepat Mon (2013) 0.76
Hepatitis C virus genotypes among multiply transfused hemoglobinopathy patients from Northern Iraq. Asian J Transfus Sci (2014) 0.76
Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma. Eur J Epidemiol (2003) 0.76
Oxidative stress response in patients infected by diverse hepatitis C virus genotypes. Hepat Mon (2015) 0.76
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40
Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A (1990) 9.98
Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol (1991) 8.33
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc Natl Acad Sci U S A (1991) 7.13
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med (1998) 6.23
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol (1992) 5.93
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis (1995) 5.53
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 5.51
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol (1993) 5.26
Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology (1992) 5.16
Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol (1991) 5.03
Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet (1990) 4.57
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest (1996) 4.10
Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A (1994) 3.76
Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A (1992) 3.72
Hepatitis C virus antibodies among risk groups in Spain. Lancet (1989) 3.66
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med (1995) 3.41
Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med (1996) 3.38
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest (1995) 3.19
Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol (1992) 3.13
Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun (1991) 3.09
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol (1994) 3.06
Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med (1990) 2.99
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Variability of hepatitis C virus. Hepatology (1995) 2.90
Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis (1995) 2.89
National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology (1997) 2.89
The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA. Virology (1992) 2.88
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun (1990) 2.61
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol (1993) 2.57
At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci U S A (1992) 2.56
Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med (1997) 2.56
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology (1995) 2.54
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1992) 2.30
Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol (1996) 2.26
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology (1991) 2.25
Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology (1995) 2.25
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet (1994) 2.01
Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology (1998) 1.95
Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology (1997) 1.90
Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion (1992) 1.82
Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A (1994) 1.81
Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol (1991) 1.74
Differences in the hepatitis C virus genotypes in different countries. J Hepatol (1993) 1.73
Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol (1996) 1.72
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology (1995) 1.69
Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol (1995) 1.65
Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol (1992) 1.59
Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med (1996) 1.56
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54
The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology (1995) 1.54
The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups. J Gen Virol (1998) 1.52
Prevalence of hepatitis C virus genotypes in Italy. J Clin Microbiol (1994) 1.47
Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol (1996) 1.46
Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol (1997) 1.43
The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J Gen Virol (1994) 1.41
Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol (1996) 1.41
Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg (1998) 1.39
Hepatitis C genotypes: current trends and future implications. Mayo Clin Proc (1996) 1.38
Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol (1997) 1.37
Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J Gen Virol (1998) 1.27
Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology (1991) 1.26
Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol (1994) 1.26
Natural course of chronic hepatitis C. Am J Gastroenterol (1993) 1.25
Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J Gen Virol (1994) 1.25
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology (1997) 1.24
Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology (1992) 1.24
A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol (1993) 1.23
Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology (1997) 1.21
Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol (1998) 1.20
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol (1997) 1.19
Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut (1993) 1.19
Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology (1996) 1.19
Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis. Virology (1993) 1.17
Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut (1996) 1.17
Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci (1994) 1.15
Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology (1997) 1.10
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol (1990) 1.09
Review: molecular epidemiology of hepatitis C virus. J Gastroenterol Hepatol (1997) 1.06
Classification of hepatitis C virus variants in six major types based on analysis of the envelope 1 and nonstructural 5B genome regions and complete polyprotein sequences. J Gen Virol (1997) 1.04
Distribution of plural HCV types in Japan. Biochem Biophys Res Commun (1991) 1.03
Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol (1995) 1.02
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J Hepatol (1997) 1.01
Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene (1991) 1.00
Molecular analysis of intraspousal transmission of hepatitis C virus. J Hepatol (1995) 0.98
Serological reactivity and viral genotypes in hepatitis C virus infection. J Clin Microbiol (1995) 0.95
Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay. A clinicopathologic study and demonstration of the usefulness of a third-generation assay. Dig Dis Sci (1996) 0.95
Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation (1997) 0.94